By hmimcu 
What if your grandfather could manage his diabetes without cumbersome test strips and confusing information? What if a 7-year-old with diabetes didn’t have to deal with the nervousness or fear every time he pricked his finger? These are the hurdles that current continuous glucose monitoring (CGM) technology has overcome, and the problems that ADI has solved by embedding breakthrough technology in continuous glucose monitoring (CGM) devices.
CGM is a mobile device for diabetics that inserts a tiny sensor under the skin to test blood sugar levels around the clock. It is a better solution for quickly and accurately monitoring diabetes, with both patients and their doctors having access to real-time information without the many obstacles posed by traditional testing methods.
But it’s not a perfect solution – at least not yet. The main obstacle to CGM technology solutions has always been the combination of size, weight and power (SWaP). After all, a CGM is a portable vital signs monitoring (VSM) device that is usually worn on the arm or stomach of a diabetic. However, because it needs to stay powered in order to collect data, it is difficult to design it to work properly without affecting the size of the wearer.
As a leader in digital health solutions, particularly in the areas of wearable technology and chronic disease management, ADI has the expertise to meet this SWaP challenge. They have been working hard to help CGM technology manufacturers, particularly China’s Meiqi, develop smaller and smarter devices with touch scren. Helps to implement a new generation of convenient and low interference VSM technology.
As digital health moves closer to the forefront of the international healthcare conversation, the demand for VSM technology has increased dramatically. The global demand for digital health innovation is at an unprecedented level, especially technology that can keep people healthy and out of the hospital. In this sense, independent surveillance systems that can send information directly to doctors and the cloud also contribute to the development of public health and accessibility in an indirect way.
Progress in the VSM area is critical for communities such as people with diabetes and healthcare professionals. With the widespread application of VSM technology, patients with diabetes can achieve precision and proactive data collection that fingertip blood testing methods cannot achieve. What if your grandfather had the tools he needed to prevent complications such as blood vessel damage, heart disease, stroke and kidney disease, and had advance information about his diabetes? Or what if seven-year-old girls could wear a cool little computer on their arm to monitor their health, instead of getting the dreaded needling? We believe there are many similar cases that can lead to happier and healthier lives. The increase in data enables patients to proactively manage their own health, thereby reducing the burden on healthcare systems by reducing hospital admissions and the need for emergency treatment.
Personal impact of continuous glucose monitoring (CGM) techniques